Sign up
Quantellect · Congress · Issuer Profile
NASDAQ: MRNAModerna Inc
HealthcareMkt Cap $88.52BCongress ownership rank #354

Moderna Inc Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 76 trades in Moderna Inc (NASDAQ: MRNA) since 2020, across 8 members, worth an estimated $1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 41 buys against 35 sells, a modestly buy-led skew, with Democratic members responsible for 93% of the trades and Republican members 7%. The most recent disclosure shown was filed November 2026, and Rohit Khanna has filed the most MRNA transactions among those shown, with 11. Other recent filers include Gilbert Cisneros and Maria Elvira Salazar. One notable disclosed move was a purchase by Rohit Khanna on January 29, 2026, up 320.0% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Moderna Inc's current Quantellect Tide Score is 51 out of 100 (High Tide), Top 49% of universe (3865); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Moderna Inc (MRNA) stock overview and the complete trade table below.

Data updated

Trades
15
Politicians
3
Filings
9
Disclosed Vol
$120.01K
Buys
10
67%
Sells
5
33%

Price & congressional trade timeline

Party breakdown

Moderna congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Nov 10, 2026Oct 20, 202621 daysBuy
$1,001 - $15,000
-18.71%Self
Nov 5, 2026Oct 13, 202623 daysBuy
$1,001 - $15,000
-9.00%Spouse
Oct 7, 2026Sep 24, 202613 daysSell
$1,001 - $15,000
+1.01%Self
Oct 7, 2026Sep 11, 202626 daysBuy
$1,001 - $15,000
+36.69%Child
Oct 7, 2026Sep 4, 202633 daysBuy
$1,001 - $15,000
+35.20%Spouse
Sep 4, 2026Aug 24, 202611 daysBuy
$1,001 - $15,000
+41.69%Spouse
Sep 9, 2026Aug 19, 202621 daysSell
$1,001 - $15,000
+12.85%Self
Sep 9, 2026Aug 19, 202621 daysBuy
$1,001 - $15,000
+12.85%Self
Sep 4, 2026Aug 3, 202632 daysSell
$1,001 - $15,000
+256.89%Spouse
Jul 6, 2026Jun 30, 20266 daysBuy
$1,001 - $15,000
+181.01%Spouse
Go to

Moderna (MRNA) congressional trading FAQ

Can members of Congress legally trade Moderna (MRNA) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Moderna (MRNA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional Moderna (MRNA) trades public?

Yes. Every congressional trade in Moderna (MRNA) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Moderna (MRNA)?

Members of Congress have disclosed 76 trades in Moderna (MRNA) worth $1M across 8 members, according to public STOCK Act filings.

Which members of Congress have traded Moderna (MRNA)?

Recent and active filers of Moderna (MRNA) disclosures include Rohit Khanna, Maria Elvira Salazar, Gilbert Cisneros. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade Moderna (MRNA) more?

Across disclosed Moderna (MRNA) trades, 93% were by Democrats and 7% by Republicans, led by Democrats (93%).

What is the most recent congressional Moderna (MRNA) trade?

The most recent disclosed Moderna (MRNA) filing reported a buy by Gilbert Cisneros, filed Nov 9, 2026.

What is Moderna (MRNA)'s Tide Score?

Moderna (MRNA) has a Quantellect Tide Score of 51 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewModerna (MRNA) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.